financetom
Business
financetom
/
Business
/
Bill Holdings Stock Plunges On Q2 Earnings: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bill Holdings Stock Plunges On Q2 Earnings: What's Going On?
Feb 6, 2025 2:33 PM

BILL Holdings Inc ( BILL ) shares are diving in Thursday’s after-hours session after the company reported second-quarter financial results. Here’s a rundown of the report.

Q2 Revenue: $362.55 million, versus estimates of $360.23 million

Q2 Adjusted EPS: 56 cents, versus estimates of 46 cents

Total revenue increased 14% year-over-year, while core revenue climbed 16%. Core revenue consists of subscription and transaction fees. The company ended the quarter with $1.57 billion in cash and cash equivalents.

“We delivered strong financial results and innovated at a rapid pace as we executed on our vision to be the de facto intelligent financial operations platform for SMBs,” said René Lacerte, founder and CEO of Bill Holdings ( BILL ).

“We are leveraging our leadership position to empower small and mid-sized businesses and the partners that we serve, and we are extending our lead by expanding the depth and breadth of our platform and diverse distribution ecosystem. Today, more than 480,000 businesses rely on BILL to manage their day-to-day financial workflow. We are moving fast to address a vast market opportunity to transform the financial operations for millions of SMBs.”

See Also: Amazon.com Q4 Earnings: Jassy Highlights ‘Successful’ Holiday Season, Q1 Guidance Disappoints Investors

What’s Next: Bill Holdings ( BILL ) expects third-quarter revenue of $352.5 million to $357.5 million versus estimates of $360.36 million. The company sees third-quarter adjusted earnings in the range of 35 cents to 38 cents per share versus estimates of 34 cents per share, according to Benzinga Pro.

Bill Holdings ( BILL ) also raised its full-year outlook. The company expects full-year revenue of $1.45 billion to $1.47 billion versus estimates of $1.46 billion. Bill expects full-year adjusted earnings to be between $1.87 and $1.97 per share.

Management is currently discussing the quarter on a conference call that started at 4:30 p.m. ET.

BILL Price Action: Bill Holdings ( BILL ) shares were down 31.76% after hours, trading at $65.75 at the time of publication Thursday, according to Benzinga Pro.

This illustration was generated using artificial intelligence via Midjourney.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CENCOSUD S.A. ANNOUNCES TENDER RESULTS AND EXPIRATION TIME OF CASH TENDER OFFER FOR ANY AND ALL OF ITS OUTSTANDING 4.375% NOTES DUE 2027 (CUSIP Nos. 15132H AH4; P2205J AQ3 / ISIN Nos. US15132HAH49; US
CENCOSUD S.A. ANNOUNCES TENDER RESULTS AND EXPIRATION TIME OF CASH TENDER OFFER FOR ANY AND ALL OF ITS OUTSTANDING 4.375% NOTES DUE 2027 (CUSIP Nos. 15132H AH4; P2205J AQ3 / ISIN Nos. US15132HAH49; US
Apr 13, 2026
SANTIAGO, Chile, April 13, 2026 /PRNewswire/ -- Cencosud S.A. (the Company) today announced the tender results in connection with its offer to purchase for cash any and all of its outstanding 4.375% Notes due 2027 (the Notes) (the Offer). The Offer was made upon the terms and subject to the conditions (including the Financing Condition (as defined in the Offer...
Volato Group and M2i Global Target Late-May Close for Proposed Critical Minerals Merger After Form S-4 Declared Effective
Volato Group and M2i Global Target Late-May Close for Proposed Critical Minerals Merger After Form S-4 Declared Effective
Apr 13, 2026
Regulatory Milestone Clears Path to Shareholder Vote and Transaction Completion. ATLANTA & RENO, Nev.--(BUSINESS WIRE)-- Volato Group, Inc. ( SOAR ) (the “Company” or “Volato”) and M2i Global, Inc. ( MTWO ) (“M2i Global”) today announced that the U.S. Securities and Exchange Commission has declared effective the Registration Statement on Form S-4 relating to Volato’s proposed merger with M2i Global...
Spyre Therapeutics' SPY001 to Treat Ulcerative Colitis Meets Phase 2 Trial Endpoints; Shares Surge Pre-Bell
Spyre Therapeutics' SPY001 to Treat Ulcerative Colitis Meets Phase 2 Trial Endpoints; Shares Surge Pre-Bell
Apr 13, 2026
07:59 AM EDT, 04/13/2026 (MT Newswires) -- Spyre Therapeutics ( SYRE ) said Monday that its SPY001 investigational treatment for moderate-to-severely active ulcerative colitis met its primary, and key secondary endpoints in a phase 2 trial. The biotech firm said SPY001 was generally well tolerated by patients in the study, with no major safety concerns reported so far. Spyre also...
ALT5 Sigma Corporation Reports Full Year 2025 Financial Results
ALT5 Sigma Corporation Reports Full Year 2025 Financial Results
Apr 13, 2026
ALT5's core fintech platform continued to scale in 2025, supported by growth across payments, trading, and settlement processing of approximately $3.5 billion in transaction volume during the year ALT5 strengthened its operating foundation through compliance restoration, governance upgrades, and continued platform expansion following the acquisition of Mswipe Recent initiatives demonstrate the Company's strategy to extend its core institutional infrastructure into...
Copyright 2023-2026 - www.financetom.com All Rights Reserved